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RESEARCH ARTICLE
Gluten-free diet intervention reduces thiamine intake in two weeks,
increases glycaemic response and decreases body weight in four weeks,
with no long term nutritional deficiencies
Lucy Goddarda, Lina Begovicha, Iva Tokica, Miriam E. Cleggb and Pariyarath Sangeetha Thondrea
aDepartment of Sport, Health Sciences and Social Work, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK;
bDepartment of Food and Nutritional Sciences, University of Reading, Whiteknights, Reading, UK
ABSTRACT
This research investigated the effects of gluten free diet (GFD) on nutritional intake, glycaemic
and insulin response. In a cross-sectional study, participants who consumed gluten-containing
diet (GCD; n¼ 11) and GFD (n¼ 11) completed a food diary, blood glucose and insulin measure-
ments. In a pre-post intervention study (n¼ 11), glycaemic and insulin responses were tested
before and after four weeks of a GFD. Food intake was recorded before and after two weeks. No
significant differences in nutrient intake, glycaemic or insulin responses were found in the cross-
sectional study. In the intervention study, there was a significant reduction in body weight
(p¼ .007) and body mass index (BMI) (p¼ .004) after four weeks and lower thiamine intake
(p¼ .021) after two weeks of GFD. Glycaemic response was significantly higher (p< .05) following
GFD with no differences in insulin response. These differences were not evident if GFD was fol-
lowed for a longer period, possibly due to improved food choices.
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Gluten, a protein derived from wheat, rye and barley,
contributes to the network formation that affects the
structure, texture and rheological properties of a food
(Capriles and Arêas 2014). The omission of gluten
results in a product that has different organoleptic
qualities and an altered nutritional profile. This has
important implications for those who rely on a glu-
ten-free diet (GFD) such as those with coeliac disease,
which affects 1% of the population, where avoiding
gluten is the only method of achieving complete
remission of symptoms (NICE 2015). Since GC cereals
provide a source of valuable nutrients, their avoidance
is speculated to induce nutritional deficiencies
(Lamacchia et al. 2014).
Based on analysis of food labels and nutrition data-
bases, there is agreement that Gluten free products
(GFP), including bread and pasta, have a higher fat
content (Kulai and Rashid 2014; Miranda et al. 2014;
Allen and Orfila 2018; Fry et al. 2018; Jamieson et al.
2018). Although fat is utilised by manufacturers to
improve palatability, flavour and overall acceptance of
GFP, it concurrently reduces the nutritional value and
increases energy density. This is exemplified by previ-
ous research, which found that women following a
GFD had a significantly higher energy intake than
those who were not on a GFD (Wild et al. 2010;
Martin et al. 2013). This has important implications
for health as often GF labels are used to promote sales
due to their perceived health benefits (Faulkner et
al. 2014).
The evidence remains more ambiguous when con-
sidering other nutrients. Sugar is used to improve the
sensory profile of GFP, however, there is no clear
trend that the sugar content is higher (Fry et al. 2018;
Jamieson et al. 2018). Similarly, individuals who
adopted a GFD had a lower fibre intake in one study
(Miranda et al. 2014), but this disputes the findings of
others who found a higher fibre content in GFP
(Kulai and Rashid 2014; Allen and Orfila 2018). GFP
have been shown to be an inferior source of protein
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and evidence exists that those on a GFD have a lower
protein intake (Kulai and Rashid 2014; Miranda et al.
2014; Missbach et al. 2015; Wu et al. 2015; Allen and
Orfila 2018; Fry et al. 2018; Jamieson et al. 2018;
Calvo-Lermaet al. 2019). Notably, individuals exam-
ined before and after diagnosis of coeliac disease had
significant decrease in protein intake following com-
mencement of the GFD (Shepherd and Gibson 2013).
However, the opposite was found in a sample where
93.2% incorporated GF rendered products each day
(Martin et al. 2013).
There have been concerns regarding the micronu-
trient intake of those following a GFD. In previous
studies, the serum folate concentrations of GF partici-
pants were below that of the controls (Shepherd and
Gibson 2013; Valente et al. 2015), and thiamine and
iron levels were below the national average (Wild et al.
2010; Martin et al. 2013). This could be due to the lack
of mandatory fortification of GF flours, but it raises a
concern for those adopting a GFD for health gains.
Dall’Asta et al. (2012) found those on a GFD con-
sumed more crackers and sweets and less fruits and
vegetables, perhaps contributing to the higher intake of
energy, particularly fat. GF pastas and breads have a
high GI, likely due to the favourable interaction of glu-
ten on starch digestion (Segura and Rosell 2011;
Johnston et al. 2017). Furthermore, coeliac subjects
were reported to have poorer glycaemic response than
healthy subjects (Bacchetti et al. 2014). There is a need
to further establish the glycaemic and insulin response
of the GFD in the absence of coeliac disease where
confounding factors may influence results.
The existing literature indicates discrepancies in the
nutritional adequacy of a GFD, which has led to two
studies. Study one aimed to evaluate the differences in
nutrient intake, glycaemic response and insulin
response in those who followed a GFD compared to
those who consumed a GCD. Study two aimed to
investigate the effect of a four-week GFD intervention
on nutrient intake, glycaemic response and insulin
response in those who normally consumed a GCD. We
hypothesised that a GFD will result in a lower intake
of micronutrients, fibre and protein and a higher intake
of fat than a GCD. We also hypothesised that partici-
pants on GFD will have higher glycaemic and insulin
response than those who consumed GCD.
Materials and methods
Participants and study design
Participants were recruited using posters, advertise-
ments on social media, local websites and informal
recruitment through personal networks. Interested
participants were sent the relevant participant infor-
mation sheet, consent form, health questionnaire and
food diary. The exclusion criteria were a BMI over
30 kg/m2 or an overnight fasting blood glucose above
6.1mmol/L. Inclusion criteria were those aged
18–60 years old with no medical condition or any
medications that interfere with glucose metabolism or
insulin signalling. Additionally, for study one, partici-
pants in the GFD group were required to have been
adhering to the GFD for at least one month.
Participants gave written informed consent before tak-
ing part in the study.
Protocol
The study protocol was approved by the Department
and University Research Ethics Committees at Oxford
Brookes University (UREC 181234; DREC 0419_55)
according to the Declaration of Helsinki on Human
Rights. Study one was a cross-sectional study in indi-
viduals who habitually followed a GFD or a GCD.
Participants were tested once for glycaemic response
and insulin response during an oral glucose tolerance
test (OGTT). Each participant completed a 3-d weighed
food diary once. Study two was a pre–post intervention
study in which participants who habitually consumed
GCD were asked to follow a strict GFD for four weeks.
Before (week 0) and after the intervention (week 4),
the participants were tested for glycaemic response and
insulin response during an OGTT. Participants in study
two were given a list of GF food products (Table 1) to
choose and include in their diet. In Weeks 0 and 2,
they were asked to complete a 3-d weighed food diary
to determine differences in energy and nutrient intake
before and during a GFD.
Anthropometric measurements
The evening before attending the laboratory, partici-
pants were advised to avoid the consumption of caf-
feine, alcohol and nicotine, avoid strenuous exercise
and fast for 12 h. Their height was measured using a
stadiometer (Seca Limited, Birmingham, UK) and
body weight, BMI and total fat percentage were meas-
ured using the Tanita BC-418MA segmental body
composition analyser (Tanita UK Limited, Yiewsley,
UK). Waist circumference was measured using a
standard tape. Resting blood pressure was measured
using an automated sphygmomanometer (A&D
Medical UA-767 Plus, Saitama, Japan) . If the eligibil-
ity criteria were met, an OGTT was commenced.
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Blood glucose measurements during OGTT
Blood glucose was measured using a finger-prick
blood sample with a single-use lancet system
(Unistick 3, Owen Munford, Woodstock, UK). After
the first two drops of blood were discarded, 5 ml
blood was drawn into a micro cuvette and inserted
into the glucose analyser (Glucose 201þ, Hemocue
AB, Sweden). Measurements were taken at 0min (in
the fasted state) and then 15, 30, 45, 60, 90 and
120min following consumption of a glucose drink
(82.4 g glucose dissolved in 200ml of water), equiva-
lent to 75 g of available carbohydrate. The change in
blood glucose concentration was calculated by sub-
tracting the baseline blood glucose from the measure-
ment at each time point. The incremental area under
the curve (iAUC) was calculated geometrically using
the trapezoidal rule. The procedure used is an adapta-
tion of that used by Brouns et al. (2005) and falls
within FAO/WHO (1998) and the ISO (2010) recom-
mendations for determining glycaemic response.
Insulin measurement
At the same time points during the OGTT, 300 ml of
capillary blood was collected into chilled microvetteVR
capillary blood collection tubes (CB 300 K2E; Sarstedt
Ltd, Boston, UK), which were centrifuged at 4000 rpm
for 10min to obtain 200 ll supernatant plasma
(Centrifuge MC-6; Sarstedt Ltd). The plasma was
stored frozen below 20 C until insulin analysis
using an enzyme-linked immunosorbent assay
(Crystal Chem, Zaandam, Netherlands) and the
absorbance was measured by a plate reader (Spectra
Max I3, Molecular Devices, Wokingham, UK) at two
wavelengths (450 and 630 nm). A four parametric
curve fit was used for evaluation of the calibration
Table 1. A list of foods given to the participants to choose gluten-free products in study two. (Source: Coeliac UK; www.coeliac.
org.uk).
Gluten free Check to confirm Not gluten free
Grains and alternatives Amaranth, buckwheat, chestnut,
corn (maize), millet, polenta
(cornmeal), quinoa, rice, sago,
sorghum, soya, tapioca, teff
Barley, bulgar wheat, couscous,
dinkel, durum wheat, einkorn,
emmer wheat, Farro, Khorasan
wheat (commercially known as
Kamut), rye, semolina, spelt,
triticale, wheat
Flours All flours that are labelled
gluten free
Flours made from wheat, rye or
barley, e.g. plain flour, self-rising
flour, etc.
Oats Oats, oatcakes Porridge oats, oat milk, oat-based
snacks that are not labelled
gluten free
Breads, cakes and biscuits All products labelled gluten free
including biscuits, breads, cakes,
crackers, muffins, pizza bases,
rolls, scones
Macaroons, meringues All biscuits, breads, cakes, chapattis,
crackers, muffins, pastries and
pizza bases made from wheat,
rye or barley flour
Breakfast cereals All products labelled gluten free
including millet porridge, muesli,
rice porridge, corn and rice-
based cereals
Buckwheat, corn, millet and rice-
based breakfast cereals and




Pasta and noodles All products labelled gluten free
including corn (maize) pasta,
quinoa pasta, rice pasta
Rice noodles, buckwheat noodles Canned, dried and fresh wheat
noodles and pasta
Meat and poultry All fresh meats and poultry, cured
pure meats, plain cooked meats,
smoked meats
Any meat or poultry marinated or
in a sauce, burgers, meat pastes,
pates, sausages
Meat and poultry cooked in batter
or breadcrumbs, breaded ham,
faggots, haggis, rissoles
Meatless alternatives Plain tofu Marinated tofu, soya mince, falafel,
vegetable and bean burgers
Fish and shellfish All dried, fresh, kippered and
smoked fish, shellfish, fish
canned in brine, oil and water
Fish pastes, fish pates, fish in sauce Fish or shellfish in batter or
breadcrumbs, fish cakes, fish
fingers, taramasalata
Cheese and eggs All cheese and eggs Scotch eggs
Milk and milk products All milk (liquid and dried), all cream
(single, double, whipping,
clotted, soured and creme
fraiche), buttermilk, plain
fromage frais, plain yoghurt
Coffee and tea whiteners, fruit and
flavoured yoghurt or fromage
frais, soya desserts, rice milk,
soya milk, nut milks
Yoghurt with muesli or wholegrains
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curve plotted using change in absorbance of the cali-
brators against their corresponding insulin concentra-
tion and the trapezoidal rule was used to calculate the
insulin iAUC.
Dietary assessment
Participants completed a 3-d weighed food diary,
detailing the manufacturer and cooking methods of
foods on two weekdays and 1 weekend day to account
for potential variations in eating habits (Yang et al.
2014). Completed food diaries were analysed with
Nutritics Version 5.094 (Nutritics Ltd, Dublin,
Ireland). Adequate energy and nutrient intake was
established by comparison of measured intake against
the UK Dietary Reference Values (DRV) (PHE 2016).
Statistical analysis
Sample size in previous studies (Vici et al. 2016)
ranged from 13 to over 100 participants. In the cross-
sectional study, a sample size of 10 participants was
required in the GFD and GCD groups to detect a dif-
ference in glucose iAUC of 120mmol/l/min with a SD
of 90mmol/l/min in order to have a power of 80%
with a two-sided significance level of 0.05. In the pre-
post intervention study, for 80% power with a two-
sided significance level of 0.05, a sample size of 11 par-
ticipants was required to detect a difference in glucose
iAUC of 100mmol/l/min with a SD of 105mmol/l/
min. A difference in glucose iAUC of 100mmol/l/min
is deemed sufficient to detect a significant difference in
glycaemic response (Augustin et al. 2015).
Statistical analysis was performed on SPSS (IBM
SPSS Statistics for Windows, version 25.0. IBM Corp,
Armonk, NY). Descriptive statistics were presented as
mean ± standard deviation. Shapiro–Wilk Test of
Normality was used to indicate the distribution of
data. In study one, an independent t-test was per-
formed for parametric data and the Mann–Whitney
test was used for non-parametric data. Nominal varia-
bles were analysed using the chi-square test. In study
two, normally distributed data were analysed using
paired T-test and a Wilcoxon signed-rank test was
used for non-parametric data. p Values of <.05 and




A total of 22 participants were enrolled in the study;
11 followed GFD and 11 followed GCD (Table 2).
Overall, there was a higher proportion of women in
the study (91% in the GFD group and 65% in the
GCD group), although this difference was not statis-
tically significant (p¼.056 by v2). Participants in the
GFD group followed the diet for reasons including
gluten intolerance (n¼ 2), coeliac disease (n¼ 1) as
well as following it for its perceived health benefits or
due to their own interest (n¼ 8). One participant in
the GFD group did not consume dairy but no other
dietary issues were stated. Groups were homogenous
with no significant differences in age, weight, BMI,
waist circumference, body fat percentage or blood
pressure between the two groups (Table 2, p> .05).
Study two
Eleven healthy participants (4 male and 7 female) aged
22–29 years were included in the study (Table 3). At the
Table 2. Characteristics of participants who followed Gluten-containing diet (n¼ 11) and Gluten-free diet (n¼ 11) in study one.
Diet type Mean ± SD p Value
95% CI
zLL UL
Age (years) GC 30 ± 9.0 .791 1.87
GF 29 ± 9.0
Weight (kg) GC 73.1 ± 14.7 .115 2.55 21.72 –
GF 63.5 ± 12.5
BMIa (kg/m2) GC 23.4 ± 2.8 .711 2.32 3.33 –
GF 22.8 ± 3.5
Waist circumference (cm) GC 76.5 ± 8.5 .122 1.54
GF 72.3 ± 7.7
Body fat (%) GC 23.4 ± 9.0 .274 9.94 3.04 –
GF 26.9 ± 4.5
Systolic blood pressure (mmHg) GC 114.4 ± 6.6 .413 4.56 10.63 –
GF 111.4 ± 9.6
Diastolic blood pressure (mmHg) GC 73.6 ± 7.2 .616 9.0 5.47 –
GF 75.4 ± 8.5
Baseline glucose (mmol/L) GC 4.8 ± 0.5 .250 0.24 0.64 –
GF 4.6 ± 0.5
Baseline Insulin (mU/L) GC 3.6 ± 3.0 .551 – – 0.60
GF 3.2 ± 2.7
aBMI was calculated as weight/height2.
CI: confidence interval; LL: lower limit; UL: upper limit; z: standardised score; BMI: body mass index
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end of the 4-week GFD intervention, BMI and weight
of the participants were significantly lower compared to
the baseline (p< .05). Waist circumference, body fat
percentage, fasting blood glucose, fasting plasma insulin
and blood pressure changes were not statistically signifi-
cant following the GFD intervention (Table 3).
Table 3. Participant characteristics (n= 11) before and after the Gluten-free diet intervention in study two.
Diet phase Mean ± SD p Value
95% CI
Effect sizeLL UL
Weight (kg) Pre GFD 72.6 ± 16.6 .007 0.50 2.40 0.09
Post GFD 71.2 ± 16.6
BMIa (kg/m2) Pre GFD 24.2 ± 3.5 .004 0.20 0.78 0.14
Post GFD 23.7 ± 3.6
Waist circumference (cm) Pre GFD 76.2 ± 10.6 .072
Post GFD 75 ± 10.9
Body fat (%) Pre GFD 25.3 ± 7.7 .127 0.44 3.02
Post GFD 24.0 ± 8.1
Systolic blood pressure (mmHg) Pre GFD 113.7 ± 14.4 .423 5.43 11.83
Post GFD 110.5 ± 8.9
Diastolic blood pressure (mmHg) Pre GFD 73.5 ± 9.9 .682 6.08 8.88
Post GFD 72.1 ± 9.9
Baseline glucose (mmol/L) Pre GFD 4.6 ± 0.5 .595 0.25 0.41
Post GFD 4.5 ± 0.5
Baseline insulin (mU/L) Pre GFD 3.7 ± 4.0 .551 2.55 1.45
Post GFD 4.3 ± 2.8
aBMI was calculated as weight/height2.































































Gluten containing diet Gluten free diet
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Figure 1. Change in (a) blood glucose concentration (mean± SEM) and (b) plasma insulin concentration (mean± SEM) in the GFD
and GCD group during OGTT. GFD: Gluten free diet; GCD: Gluten-containing diet; OGTT; oral glucose tolerance test.
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Glucose and insulin response
Study one
The glucose and insulin concentrations in each group
peaked at 30min after consumption of the glucose
drink, with no significant difference at any time point
between groups (p> .05). The mean glucose iAUC for
the GCD group was 246.7 ± 130.9mmol/l/min, not sig-
nificantly different to the GFD group (265.2 ±
124.6mmol/l/min; p¼ .736, 95% CI [131.64, 94.62];
Figure 1(a)). The mean insulin iAUC was
2761± 1207mU/l/min for the participants on GCD and
2884± 1518mU/l/min for the participants on GFD,
p¼ .943, CI 95% [1202.18, 1288.13] (Figure 1(b)).
Study two
After the 4-week GFD intervention, a significant dif-
ference was noted during the OGTT, at 15min
(p¼ .016) and 30min (p¼ .006) after the glucose
drink ingestion. The iAUC for glucose response
during the OGTT was 8% higher after the GFD
intervention compared to the baseline
(315.6 ± 168mmol/l/min versus 292 ± 136mmol/l/min)
(Figure 2(a)). No significant difference was detected
in iAUC for plasma insulin response during the
OGTT session before (3473.3 ± 1514mU/l/min) and

































































Figure 2. Change in (a) blood glucose concentration (mean± SEM) and (b) plasma insulin concentration (mean± SEM) during
OGTT before and after the 4-week GFD intervention. Asterisk () denotes a significant difference (p<.05). OGTT: oral glucose toler-
ance test; GFD: Gluten free diet.
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Nutrient intake
Study one
Food diary analysis revealed that those on a GFD
consumed less overall energy and nutrients (Table 4).
Although the differences did not demonstrate
statistical significance, the calorie intake in those on a
GFD was 500 kcal below the recommended intake for
females (p¼ .06). All the participants had fibre and
carbohydrate intake below the UK DRVs (PHE 2016).
The protein intake of both groups was above the
Reference Nutrient Intake (RNIs) that is recom-
mended for the general population. Additionally, free
sugar and fat intake were below the UK recommended
value in both groups. Specifically, free sugar intake
was 44% below DRVs in GCD group and 61% below
DRVs in GFD group (PHE 2016). The iron intake for
both groups was below the higher, female recom-
mended value of 14.8mg and those who followed a
GFD failed to meet the RNI for folate and thiamine
whilst those in the GCD group were within the RNI
for both these nutrients (PHE 2016).
Study two
After a 2-week GFD intervention, the participants pre-
sented a significantly lower thiamine intake (p¼.021).
Although energy, fat, protein, free sugar, sodium,
Table 4. The average daily energy and nutrient intake for participants in the gluten-containing diet group and gluten-free diet
group (study one).
Nutrient Diet type Mean ± SD p Value
95% CI
zLL UL
Energy (kcal) GC 2097.6 ± 909.4 .06 33.93 1233.20 –
GF 1497.9 ± 339.1 – – – –
Fat (g) GC 75.5 ± 35.1 .49 – – 0.69
GF 60.7 ± 13.8 – – –
Protein (g) GC 95.9 ± 47.2 .10 – – 1.65
GF 67.7 ± 17.9 – – – –
Carbohydrate (g) GC 223.4 ± 85.0 .07 4.86 120.46 –
GF 165.6 ± 51.9 – –
Fibre (g) GC 26.1 ± 10.2 .61 6.86 11.44 –
GF 23.9 ± 10.3 – –
Free Sugar (g) GC 16.8 ± 10.0 .21 3.14 13.34 –
GF 11.7 ± 8.5 – – – –
Iron (mg) GC 10.9 ± 5.0 .14 1.03 6.89 –
GF 8.0 ± 3.8 – – – –
Folate (ug) GC 267.8 ± 137.4 .07 4.79 185.70 –
GF 177.4 ± 63.7 – – – –
Thiamine (mg) GC 1.7 ± 1.3 .07 – – 1.81
GF 1.0 ± 0.4 – – – –
CI: confidence interval; LL: lower limit; UL: upper limit
Table 5. Nutritional intake before and after the 4-week Gluten-free diet intervention (study two).




Energy (kcal) Pre GFD 1877.0 ± 945.8 .286 – – – 1.07
Post GFD 1681.0 ± 670.5 – – –
Fat (g) Pre GFD 70.1 ± 35.9 .350 – – – 0.94
Post GFD 64.2 ± 65.6 – – – –
Protein (g) Pre GFD 106.3 ± 66.8 .091 – – – 1.69
Post GFD 94.3 ± 65.6 – – –
Carbohydrate (g) Pre GFD 197.0 ± 97.5 .374 – – – 0.89
Post GFD 174.6 ± 68.9 – – – – –
Fibre Pre GFD 24.8 ± 10.4 .378 3.02 7.29 – –
Post GFD 22.7 ± 8.8 – – – – –
Free sugars (g) Pre GFD 13.4 ± 11.1 .857 7.09 8.37 –
Post GFD 12.7 ± 11.2 – – – – –
Sodium (mg) Pre GFD 1834.0 ± 885.7 .091 – – – 1.69
Post GFD 1348.0 ± 606.8 – – – – –
Calcium (mg) Pre GFD 719.6 ± 400.9 .276 114.43 360.06 – –
Post GFD 596.7 ± 244.8 – – – – –
Iron (mg) Pre GFD 10.7 ± 4.9 .326 1.37 3.73 – –
Post GFD 9.5 ± 5.1 – – – – –
Thiamine (mg) Pre GFD 1.7 ± 1.2 .021

– – 0.54 2.31
Post GFD 1.2 ± 0.6 – – – –
Niacin (mg) Pre GFD 44.2 ± 34.0 .424 – – – 0.80
Post GFD 42± 36.8 – – – – –
CI: confidence interval; LL: lower limit; UL: upper limit

Statistically significant difference - p < .05.
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calcium, iron and niacin intake was lower during the
GFD, the results were not significant (Table 5).
Discussion
The two studies presented here have demonstrated
that a GFD is of nutritional equity to a GCD with
both diets manifesting some nutritional imbalances.
Short-term changes in anthropometric characteristics
and glycaemic response were observed in the popula-
tion studied. The proposed hypothesis that those who
follow a GFD will have a lower intake of micronu-
trients, fibre and protein and a higher intake of fat
than those who follow a GCD is not supported by the
studies. A reduced thiamine intake was noted after 2
weeks of following a GFD and following this diet for
4 weeks led to a reduced body weight and BMI,
whereas longer-term adherence to a GFD did not
appear to influence body weight or body composition
of participants. A previous study in Australia has
attributed inadequate thiamine intake in coeliac
patients to the lack of availability of thiamine-fortified
gluten-free foods (Shepherd and Gibson 2013).
Although the UK legislation does not require gluten
free flours to be fortified with thiamine (Allen and
Orfila 2018), the result in this study warrants further
research due to the short duration of dietary assess-
ment. Although an acute effect of GFD was evident
on glycaemic response, there was a non-significant
difference in glycaemic and insulin response between
the two groups that followed GFD and GCD for a
longer period.
Body weight and BMI reduction observed in study
two conflict previous findings (Kabbani et al. 2012;
Tortora et al. 2015) that coeliac patients’ body weight
and BMI increased significantly after initiating a GFD.
These findings may not apply to the non-coeliac
population on a GFD. However, the results agreed
with significantly lower BMI and weight noted in a
GFD group (Kim et al. 2017), potentially due to low
consumption of refined carbohydrates, and a possible
increase in consumption of fruits and vegetables, sup-
porting weight-loss. Additionally, participants in study
two received dietary advice and recorded their dietary
intake, which have previously been shown to improve
nutritional quality and assist weight-loss (Ingels et
al. 2017).
Few studies have compared the glucose and insulin
response in individuals who consume gluten and
those who do not. Rather the approach has been to
examine the response following ingestion of a GFP
(i.e. GF pasta, bread) in healthy or coeliac subjects
(Segura and Rosell 2011; Johnston et al. 2017). The
hypothesis for study one was based on this evidence
and the findings do not support this, suggesting that
when the GFD is viewed in its entirety, the glucose
and insulin response are comparable to a GCD. The
results of study two, addressing the short-term effect
of the GFD found a higher glucose response after a
GFD intervention, which highlights the importance of
food choices at different stages of adopting a new
diet, which may change and improve overtime. If par-
ticipants chose natural GF foods such as quinoa or
buckwheat, which have been suggested as GF alterna-
tives with a low GI (Skrabanja et al. 2001), they may
portray a lower glycaemic and insulin response. The
effect of nutritional characteristics of a product on
physiological responses is emphasised here. Increasing
consumer knowledge about sources of GF foods
should be prioritised along with research to examine
the GF diet as a whole, in order to identify if there is
a risk of poorer glycaemic response, dependent on
food choice.
The GF group in both studies displayed a low
mean energy intake, below that of the recommended
value for both males and females (Vici et al. 2016).
The reduced food choices for individuals on a GFD
may account for this as reflected in the anthropomet-
ric measurements in the studies. However, those par-
ticipants who were following a GFD for a longer term
did not present a difference in body weight or BMI
compared to those on a GCD. Additionally, the large
standard deviation of the mean energy suggests there
was large variation in energy intake between partici-
pants. Dietary data that displayed a low-energy intake
may have skewed data towards an overall lower mean
energy and nutrient intake. It must also be considered
that the findings may be influenced by under-report-
ing or under-eating. Differing food diary durations
may account for the differences between studies how-
ever, more than 3-d, does not necessarily improve the
accuracy of results as the increased burden on partici-
pants can lead to erroneous recording (Livingstone et
al. 1990).
Previous authors have found the mean total fat
intake significantly higher in those on a GFD
(Dall’Asta et al. 2012; Miranda et al. 2014), reasoning
that this is due to choosing high fat alternatives to
achieve the same palatability of GC foods (Dall’Asta et
al. 2012). In contrast, all participants in study one had
an adequate intake of both fat and free sugar. Those
in study two on a short-term GFD also did not have a
significantly higher intake of these nutrients indicating
that the GFD is not associated with an excessive
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intake of fat and free sugar. Future research should
address the bias towards GF diet being one of a
healthier profile when nutritional equity in terms of
both fat and sugar has been observed between GFD
and GCD in both short and long term.
Fibre (especially cereal and wholegrain cereal fibre)
protects against chronic diseases and supports weight
loss (Seal and Brownlee 2015). A UK-based study
(Wild et al. 2010) found “health conscious individuals”
following a GFD and a GCD failed to meet the UK
recommendations of 30 g of fibre (SACN 2015) sup-
porting the results of this research. Similar results were
reported for both newly diagnosed and experienced GF
patients where neither met the national recommenda-
tions when consuming a GFD (Shepherd and Gibson
2013). There has been progress in the manufacturing
of GFP since fibre-rich alternative grains (quinoa,
brown rice and amaranth) have been identified as
ingredients (Lee et al. 2009). However, the evidence
presented, and the current work has highlighted the
possibility that an inadequate fibre intake is not specific
to those who follow a GFD and is in fact, embedded
within the food choices of society.
The findings of study one do not support the
hypothesis that those who consume a GFD will have a
significantly lower intake of micronutrients compared
to those who consumed a GCD. Contrary to the
above, the short-term adoption of a GFD in study two
resulted in a significantly reduced intake of thiamine
by the participants, albeit above the recommended
intake for adults. Micronutrient deficiencies have been
noted in coeliac subjects up to 10 years after diagno-
sis, perhaps due to continued malabsorption caused
by non-adherence to the GFD or underlying patholo-
gies (Hallert et al. 2002). An advantage of study one is
that only one participant had coeliac disease and all
others were deemed healthy individuals. This suggests
that if healthy individuals adopt a GFD, they are not
at an increased risk of micronutrient deficiencies than
those who consume a normal diet. It must be consid-
ered that although there was no significant difference
between groups, the mean intake of folate and thia-
mine in the participants who followed a GFD for a
longer term failed to meet the recommended intake,
which reflects the findings of others (Wild et al. 2010;
Martin et al. 2013). Should this continue to be a
recurrent finding, fortification of GFP should be con-
sidered. The current studies lack strength to drive this
change but researchers should obtain a larger sample
of healthy individuals on a GFD and perform nutri-
tional analysis via biochemical laboratory testing to
corroborate and strengthen these data on
micronutrients.
Some limitations have been acknowledged includ-
ing not assessing adherence to the GFD in both stud-
ies. Those with diagnosed coeliac disease, where
strict adherence to a GFD is medically imperative,
have been shown to display variable compliance rates
(Hall et al. 2009). Therefore, in healthy participants,
where consuming gluten does not have adverse
health consequences, poor adherence to the diet may
ensue. Furthermore, the GFD had been followed for
a range of 1 month to 45 years by participants in
study one. Despite this vast range, eliminating a food
group for at least 30 days has been shown to affect
metabolic markers; justifying these criteria and
enhancing internal validity (Yao et al. 2013). Male
participants were under represented, but as data were
not separated for gender, this does not directly influ-
ence conclusions made (Engelhardt et al. 2007). Both
studies are limited by the small sample sizes, restrict-
ing the ability to generalise to a wider population.
Despite this, the findings indicate important differen-
ces that should not be overlooked and therefore, fur-
ther exploration in a larger, and diverse sample,
is needed.
Conclusion
A comparable nutritional intake is evident in those
who follow a GFD and a GCD. Therefore, in the
absence of coeliac disease or gluten intolerance, the
GFD is unlikely to induce additional health benefits.
However, a short-term adoption of GFD may result
in reduced thiamine intake, which may become lower
than the recommended intake levels in the long
term. To obviate the nutritional deficiencies observed
in both groups, there is a public health need to
examine both diets at the individual and societal
level. The results do not support the contention that
following a GFD for a long period of time would
result in a poorer glycaemic and insulin response;
challenging the hyperglycaemic effect demonstrated
after the 4-week GFD intervention and studies that
have examined GFP alone. A switch to GFD may
reduce energy intake and induce weight loss in the
short-term due to reduced food choices. However,
when compared to those who consume a GCD, the
difference is less apparent in the long term. In view
of increasing popularity of GFD, a larger study is
needed to further challenge and substantiate its
nutritional adequacy.
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